Bellwether Advisors’s Gilead Sciences GILD Stock Holding History

Bellwether Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25	Closed	-$2.77K	–	304
2025 Q2	$2.77K	Hold	25	–	–	﹤0.01%	470
2025 Q1	$2.8K	Hold	25	–	–	﹤0.01%	415
2024 Q4	$2.31K	Buy	+25	New	+$2.25K	﹤0.01%	437
2023 Q2	–	Sell	-17	Closed	-$1.41K	–	229
2023 Q1	$1.41K	Buy	17 +1	+6%	+$83	﹤0.01%	357
2022 Q4	$1.37K	Sell	16 -60	-79%	-$4.75K	﹤0.01%	370
2022 Q3	$4K	Sell	76 -1	-1%	-$63	﹤0.01%	336
2022 Q2	$4K	Sell	77 -265	-77%	-$16.4K	﹤0.01%	300
2022 Q1	$20K	Hold	342	–	–	0.01%	254
2021 Q4	$24K	Hold	342	–	–	0.01%	256
2021 Q3	$23K	Buy	342 +326	+2,038%	+$22.9K	0.01%	235
2021 Q2	$1K	Hold	16	–	–	﹤0.01%	398
2021 Q1	$1K	Hold	16	–	–	﹤0.01%	372
2020 Q4	$0	Buy	+16	New	+$965	﹤0.01%	325

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellwether Advisors's GILD Position: Q3 2025 in Review

Bellwether Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 25 shares — an estimated $2.77K sold.

Bellwether Advisors first reported a position in GILD in Q4 2020 and held it in 13 quarters. The position peaked at $24K in Q4 2021. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Bellwether Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Bellwether Advisors sold 25 Gilead Sciences shares in Q3 2025, an estimated $2.77K.
Bellwether Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 13 quarters.
Bellwether Advisors's Gilead Sciences position peaked at $24K in Q4 2021.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.